Urgent Appeal: WMed Researchers Fear Lifesaving Studies May Halt Without Crucial NIH Funding

Admin

Urgent Appeal: WMed Researchers Fear Lifesaving Studies May Halt Without Crucial NIH Funding

KALAMAZOO, Mich. — The Trump Administration is attempting to cut federal funding for medical research, which many fear could delay crucial studies. A federal judge intervened, blocking these cuts after 22 states, including Michigan, filed a lawsuit.

Prior to this pause, the National Institutes of Health (NIH) had halted the review process for grant applications. This delay put millions of dollars in research funding on hold, affecting projects on urgent issues like cancer and Alzheimer’s disease.

One team impacted is led by Eric Larson at the Western Michigan University Homer Stryker M.D. School of Medicine (WMed). They are researching polycystic kidney disease and recently made a breakthrough that could lead to new treatment options for this currently incurable condition.

Larson expressed concern, stating, “If funding disappears, it would greatly slow down our lab work.” WMed relies heavily on NIH grants, receiving around $7 to $8 million each year to support its research initiatives.

According to WMed Dean Robert Sawyer, this funding is vital for purchasing laboratory supplies, including basic items like test tubes and animals used in experiments. He emphasized the importance of these funds, saying, “They are an extraordinary partner in our research.”

The Trump Administration argues that these cuts aim to better manage taxpayer dollars and improve government efficiency. However, the proposed policy would limit funding for indirect research costs to just 15%, down from the current 50%. This change could severely impact research efforts.

“Cuts made today will affect future generations of patients,” Sawyer warned, highlighting the long-term consequences of reduced funding for medical research.

For more on the National Institutes of Health and their work, you can visit their official website.



Source link

NIH grants,Medical research,Trump Administration,Lifesaving studies,WMed,Funding cuts,Biomedical sciences,Cancer research